Status: current, Defined. Date: 31-Jul 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3773109014 | Product containing only carmustine in prolonged-release intralesional implant (medicinal product form) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 3773110016 | Carmustine only product in prolonged-release intralesional implant | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Carmustine only product in prolonged-release intralesional implant | Is a | Carmustine-containing product in prolonged-release intralesional implant | true | Inferred relationship | Some | ||
| Carmustine only product in prolonged-release intralesional implant | Count of base of active ingredient | 1 | false | Inferred relationship | Some | ||
| Carmustine only product in prolonged-release intralesional implant | Is a | Carmustine only product | true | Inferred relationship | Some | ||
| Carmustine only product in prolonged-release intralesional implant | Has manufactured dose form | Prolonged-release intralesional implant | true | Inferred relationship | Some | ||
| Carmustine only product in prolonged-release intralesional implant | Has active ingredient | Carmustine | true | Inferred relationship | Some | 1 | |
| Carmustine only product in prolonged-release intralesional implant | Plays role | Antineoplastic therapeutic role | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Carmustine 7.7 mg prolonged-release intralesional implant | Is a | True | Carmustine only product in prolonged-release intralesional implant | Inferred relationship | Some |
This concept is not in any reference sets
FHIR